Gvoke Kit

NDC 72065-140 · Xeris Pharmaceuticals, Inc.

Generic nameglucagon injection, solution

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)GLUCAGON

Strength1 mg/.2mL

Pharmacologic classAntihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]

Marketing categoryNDA

Packages

72065-140-11 — .2 mL in 1 CARTON (72065-140-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0517-2901 — glucagon injection, 0548-8351 — glucagon, 0548-8352 — glucagon, 63083-1555 — Glucagon, 72065-120 — glucagon injection, solution, 72065-121 — glucagon injection, solution, 72065-131 — glucagon injection, solution, 85766-212 — glucagon

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels